Scientists say you can now use Osimertinib -a cancer drug- just once a week instead of daily and still be safe from tumour regrowths.
A new review reveals that rising global temperatures, increased pollution, and extreme weather events are driving a global surge in eye diseases, disproportionately affecting vulnerable communities and challenging healthcare systems.